SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-072543
Filing Date
2023-06-20
Accepted
2023-06-20 06:55:31
Documents
12
Period of Report
2023-06-16
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319018d1_8k.htm   iXBRL 8-K 28112
  Complete submission text file 0001104659-23-072543.txt   203161

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20230616.xsd EX-101.SCH 3236
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20230616_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20230616_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2319018d1_8k_htm.xml XML 3599
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 231023323
SIC: 2834 Pharmaceutical Preparations